Literature DB >> 3512346

The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values.

J C Beard, R N Bergman, W K Ward, D Porte.   

Abstract

Although the minimal-model-based insulin sensitivity index (S1) can be estimated from the results of a simple 180-min intravenous glucose tolerance test (IVGTT), its relationship to widely accepted but technically more difficult clamp-based techniques has not been resolved in humans. Therefore we measured S1 by standard IVGTT, modified IVGTT, and clamp methods in 10 nondiabetic men with %IBW of 109 +/- 12 (mean +/- SD). In the euglycemic clamp studies, insulin was infused to bring insulin levels (IRI) from basal, 8 +/- 4 microU/ml, to plateaus of 21 +/- 5 and 35 +/- 6 microU/ml. S1[clamp], measured as the increase in glucose (G) clearance per increase in IRI [delta INF/(delta IRI X G)], averaged 0.29 +/- 0.09 ml/kg X min per microU/ml. In the IVGTT studies, 300 mg/kg G was given as an i.v. bolus, and G and IRI were measured for 180 min; in the modified (mod) IVGTT, tolbutamide (300-500 mg) was given i.v. 20 min after the G to observe the effect of an IRI peak on G removal after G level was free of initial "mixing" effects. The S1 estimated by computer did not differ significantly between standard [(6.9 +/- 3.4) X 10(-4) min-1 per microU/ml] and modified [(6.7 +/- 3.5) X 10(-4) min-1 per microU/ml] tests, indicating no bias due to the differing insulin patterns and levels. There was a strong positive correlation between S1 (mod IVGTT) and S1(clamp): r = 0.84; N = 10; P less than 0.002. The correlation between S1(standard IVGTT) and S1(clamp) was 0.54, suggesting the modified test is less "noisy." Nonetheless, in eight euglycemic women with a wider range of adiposity, S1(standard IVGTT) has been significantly correlated with %IBW (r = -0.72) and basal IRI (r = -0.84). The correlation between S1 measures by clamp and IVGTT methods provides one step toward validation of the minimal model for studies of insulin action in man.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3512346     DOI: 10.2337/diab.35.3.362

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  40 in total

1.  Effect of acitretin on the response to an intravenous glucose tolerance test in healthy volunteers.

Authors:  D Hartmann; I Forgo; U C Dubach; U Hennes
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Early maternal undernutrition programs increased feed intake, altered glucose metabolism and insulin secretion, and liver function in aged female offspring.

Authors:  Lindsey A George; Liren Zhang; Nuermaimaiti Tuersunjiang; Yan Ma; Nathan M Long; Adam B Uthlaut; Derek T Smith; Peter W Nathanielsz; Stephen P Ford
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-01-25       Impact factor: 3.619

3.  Optimization of the intravenous glucose tolerance test in T2DM patients using optimal experimental design.

Authors:  Hanna E Silber; Joakim Nyberg; Andrew C Hooker; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-06-25       Impact factor: 2.745

4.  Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice.

Authors:  J McKee Alderman; Kevin Flurkey; Natasha L Brooks; Sneha B Naik; Jonathan M Gutierrez; Urmila Srinivas; Kristen B Ziara; Linhong Jing; Gunnar Boysen; Rod Bronson; Simon Klebanov; Xian Chen; James A Swenberg; Mats Stridsberg; Carol E Parker; David E Harrison; Terry P Combs
Journal:  Exp Gerontol       Date:  2008-06-07       Impact factor: 4.032

5.  Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia.

Authors:  Darcy R Barry; Kristina M Utzschneider; Jenny Tong; Kersten Gaba; Daniel F Leotta; John D Brunzell; Thomas R Easterling
Journal:  Am J Obstet Gynecol       Date:  2015-05-21       Impact factor: 8.661

6.  Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.

Authors:  D A D'Alessio; S E Kahn; C R Leusner; J W Ensinck
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Whole and refined grain intakes are related to inflammatory protein concentrations in human plasma.

Authors:  Rachel C Masters; Angela D Liese; Steven M Haffner; Lynne E Wagenknecht; Anthony J Hanley
Journal:  J Nutr       Date:  2010-01-20       Impact factor: 4.798

8.  Adipocytokines as features of the metabolic syndrome determined using confirmatory factor analysis.

Authors:  Mark M Smits; Pier Woudstra; Kristina M Utzschneider; Jenny Tong; Fernando Gerchman; Mirjam Faulenbach; Darcy B Carr; Kathryn Aston-Mourney; Alan Chait; Robert H Knopp; James B Meigs; Edward J Boyko; Steven E Kahn
Journal:  Ann Epidemiol       Date:  2013-03-25       Impact factor: 3.797

9.  Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and β-cell function in overweight adults.

Authors:  Barbara A Gower; Norman K Pollock; Krista Casazza; Thomas L Clemens; Laura Lee Goree; Wesley M Granger
Journal:  J Clin Endocrinol Metab       Date:  2013-04-24       Impact factor: 5.958

10.  Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss.

Authors:  Jonathan Q Purnell; Steven E Kahn; Mary H Samuels; David Brandon; D Lynn Loriaux; John D Brunzell
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-02       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.